title: Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: preliminary results.
abstract: Background and Aims. Intraperitoneal chemotherapy is a basic tool in the treatment of peritoneal malignancy. The purpose of the study is to investigate the effect of adjuvant perioperative intraperitoneal chemotherapy in the treatment of locally advanced colorectal cancer. Patients and Methods. Patients with T(3) and T(4) colorectal carcinomas that underwent R(0) resection received either hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC group = 40 patients) or early postoperative intraperitoneal chemotherapy (EPIC group = 67 patients). The survival, the recurrences and the sites of recurrence were assessed. Results. The 3-year survival rate for HIPEC group was 100% and for EPIC group 69% (P = .011). Nodal infiltration was found to be the single prognostic indicator of survival. The incidence of recurrence in EPIC group was higher than in HIPEC group (P = .009). The independent indicators of recurrence were the use of HIPEC and the degree of differentiation (P < .05). Conclusions. Intraperitoneal chemotherapy, particularly HIPEC, as an adjuvant in locally advanced colorectal carcinomas appears to improve survival and decrease the incidence of recurrence.
authors.affiliation: Surgical Department, Didimotichon General Hospital, Konstantinoupoleos 1, 68300 Didimotichon, Greece.
authors.forename: A A K
authors.initials: AA
authors.lastname: Tentes
authors.forename: I D
authors.initials: ID
authors.lastname: Spiliotis
authors.forename: O S
authors.initials: OS
authors.lastname: Korakianitis
authors.forename: A
authors.initials: A
authors.lastname: Vaxevanidou
authors.forename: D
authors.initials: D
authors.lastname: Kyziridis
references.citation: Eur J Surg Oncol. 2009 Nov;35(11):1186-91
references.pmid: 19356887
references.citation: Eur J Surg Oncol. 2006 Aug;32(6):597-601
references.pmid: 16617003
references.citation: Ann Surg Oncol. 1999 Dec;6(8):727-31
references.pmid: 10622499
references.citation: Br J Surg. 2007 Oct;94(10):1285-92
references.pmid: 17661309
references.citation: J Clin Oncol. 2003 Oct 15;21(20):3737-43
references.pmid: 14551293
references.citation: Lancet. 1993 Feb 20;341(8843):457-60
references.pmid: 8094488
references.citation: J Clin Oncol. 1989 Oct;7(10):1447-56
references.pmid: 2778478
references.citation: Langenbecks Arch Surg. 2007 Mar;392(2):155-60
references.pmid: 17235584
references.citation: J Surg Res. 1991 Jan;50(1):82-7
references.pmid: 1898977
references.citation: Cancer Treat Res. 1996;81:51-61
references.pmid: 8834575
references.citation: Cancer. 2006 Mar 1;106(5):1144-53
references.pmid: 16456817
references.citation: Hepatogastroenterology. 1992 Aug;39(4):304-8
references.pmid: 1427571
references.citation: Ann Surg Oncol. 2007 Oct;14(10):2702-13
references.pmid: 17653801
references.citation: Eur J Surg Oncol. 2006 Aug;32(6):686-91
references.pmid: 16621431
references.citation: Cancer Metastasis Rev. 1984;3(4):303-24
references.pmid: 6394125
references.citation: N Engl J Med. 1997 Apr 3;336(14):980-7
references.pmid: 9091798
references.citation: J BUON. 2008 Apr-Jun;13(2):205-10
references.pmid: 18555466
references.citation: Cancer Treat Res. 1996;82:79-100
references.pmid: 8849945
references.citation: Br J Surg. 1991 Jan;78(1):57-9
references.pmid: 1998866
references.citation: Ann Surg Oncol. 2007 Feb;14(2):509-14
references.pmid: 17096054
references.citation: J Surg Oncol. 2008 Sep 15;98(4):277-82
references.pmid: 18726894
references.citation: Cancer Treat Res. 1996;82:41-52
references.pmid: 8849942
references.citation: Cancer. 1996 Jun 15;77(12):2622-9
references.pmid: 8640714
references.citation: Ann Surg. 1980 Jul;192(1):114-7
references.pmid: 6157369
references.citation: Surg Gynecol Obstet. 1992 Jan;174(1):27-32
references.pmid: 1729745
references.citation: J Natl Cancer Inst. 2001 Apr 18;93(8):583-96
references.pmid: 11309435